{
    "organizations": [],
    "uuid": "2bcde35464d36290d680cd810a5bff4fde4fab73",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-saudis-al-hammadi-signs-mou-with-s/brief-saudis-al-hammadi-signs-mou-with-sudair-pharma-for-acquisition-of-equity-stake-idUSFWN1RX10Z",
    "ord_in_thread": 0,
    "title": "BRIEF-Saudi's Al Hammadi Signs MOU With Sudair Pharma For Acquisition Of Equity Stake",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 22 (Reuters) - AL HAMMADI COMPANY FOR DEVELOPMENT AND INVESTMENT:\n* SIGNS MOU WITH SUDAIR PHARMA COMPANY FOR ACQUISITION OF EQUITY STAKE\n* TERM OF MOU IS TWO MONTHS FROM DATE OF SIGNING MOU APRIL 21, 2018 AND WILL END ON JUNE 20, 2018\n* THE ACQUISITION IS IN LINE WITH AL HAMMADIâ€™S GROWTH PLANS AND THE KINGDOM VISION 2030 TO NATIONALIZE ADVANCED INDUSTRIES AND TECHNOLOGIES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-22T13:18:00.000+03:00",
    "crawled": "2018-04-23T22:18:47.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "al",
        "hammadi",
        "company",
        "development",
        "investment",
        "sign",
        "mou",
        "sudair",
        "pharma",
        "company",
        "acquisition",
        "equity",
        "stake",
        "term",
        "mou",
        "two",
        "month",
        "date",
        "signing",
        "mou",
        "april",
        "end",
        "june",
        "acquisition",
        "line",
        "al",
        "hammadi",
        "growth",
        "plan",
        "kingdom",
        "vision",
        "nationalize",
        "advanced",
        "industry",
        "technology",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}